Article: “Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study”
Autologous bone marrow derived mesenchymal stem cell (BM-MSC) transplantation is a promising method proposed as a therapy for MS. Although the safety of these cells has been confirmed in hematological, cardiac and inflammatory diseases, its efficacy in MS treatment is still under study.
Read more about this study here: http://bit.ly/1esI7F8
courtesy by: Bentham Insight
0 comments:
Post a Comment